MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress

Over three decades have passed since the first report on the expression of CA125 by ovarian tumors. Since that time our understanding of ovarian cancer biology has changed significantly to the point that these tumors are now classified based on molecular phenotype and not purely on histological attr...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Felder, Mildred, Kapur, Arvinder, Gonzalez-Bosquet, Jesus, Horibata, Sachi, Heintz, Joseph, Albrecht, Ralph, Fass, Lucas, Kaur, Justanjyot, Hu, Kevin, Shojaei, Hadi, Whelan, Rebecca J, Patankar, Manish S
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4046138/
https://ncbi.nlm.nih.gov/pubmed/24886523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-13-129
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky